Small RNAs guide hematopoietic cell differentiation and function

Journal of Immunology

Volumn 184, Issue 11, 2010, Pages 5939-5947

  Navarro, Francisco ^a   Lieberman, Judy ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

BIOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CHRONIC LYMPHATIC LEUKEMIA; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MICRORNAS;

EID: 77953365479     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902567     Document Type: Review

References (78)

1. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Davis, B. N., A. C. Hilyard, G. Lagna, and A. Hata. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
3. Suzuki, H. I., K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, and K. Miyazono. 2009. Modulation of microRNA processing by p53. Nature 460: 529-533.
4. Heo, I., C. Joo, J. Cho, M. Ha, J. Han, and V. N. Kim. 2008. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell 32: 276-284.
5. Chatterjee, S., and H. Grosshans. 2009. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 461: 546-549.
6. Ramachandran, V., and X. Chen. 2008. Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 321: 1490-1492.
7. Yang, W., T. P. Chendrimada, Q. Wang, M . Higuchi, P. H. Seeburg, R. Shiekhattar, and K. Nishikura. 2006. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13: 13-21.
8. Wu, H., C. Ye, D. Ramirez, and N. Manjunath. 2009. Alternative processing of primary microRNA transcripts by Drosha generates 59 end variation of mature microRNA. PLoS ONE 4: e7566.
9. Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
10. Johnson, S. M., H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K. L. Reinert, D. Brown, and F. J. Slack. 2005. RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
11. Lal, A., F. Navarro, C. A. Maher, L. E. Maliszewski, N. Yan, E. O'Day, D. Chowdhury, D. M. Dykxhoorn, P. Tsai, O. Hofmann, et al. 2009. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 35: 610-625.
12. Tay, Y., J. Zhang, A. M. Thomson, B. Lim, and I. Rigoutsos. 2008. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
13. Easow, G., A. A. Teleman, and S. M. Cohen. 2007. Isolation of microRNA targets by miRNP immunopurification. RNA 13: 1198-1204.
14. Hong, X., M. Hammell, V. Ambros, and S. M. Cohen. 2009. Immunopurification of Ago1 miRNPs selects for a distinct class of microRNA targets. Proc. Natl. Acad. Sci. USA 106: 15085-15090.
15. Baek, D., J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
16. Selbach, M., B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
17. Johnnidis, J. B., M. H. Harris, R. T. Wheeler, S. Stehling-Sun, M. H. Lam, O. Kirak, T. R. Brummelkamp, M. D. Fleming, and F. D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129.
18. Chen, C. Z., L. Li, H. F. Lodish, and D. P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
19. Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, and K. Rajewsky. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
20. Costinean, S., N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, N. Heerema, and C. M. Croce. 2006. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103: 7024-7029.
21. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/ microRNA-155 for normal immune function. Science 316: 608-611.
22. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
23. Xiao, C., L. Srinivasan, D. P. Calado, H. C. Patterson, B. Zhang, J. Wang, J. M. Henderson, J. L. Kutok, and K. Rajewsky. 2008. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9: 405-414.
24. Ventura, A., A. G. Young, M. M. Winslow, L. Lintault, A. Meissner, S. J. Erkeland, J. Newman, R. T. Bronson, D. Crowley, J. R. Stone, et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886.
25. He, L., J. M. Thomson, M. T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S. W. Lowe, G. J. Hannon, and S. M. Hammond. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
26. Monticelli, S., K. M. Ansel, C. Xiao, N. D. Socci, A. M. Krichevsky, T. H. Thai, N. Rajewsky, D. S. Marks, C. Sander, K. Rajewsky, et al. 2005. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 6: R71.
27. Neilson, J. R., G. X. Zheng, C. B. Burge, and P. A. Sharp. 2007. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21: 578-589.
28. Georgantas, R. W., III, R. Hildreth, S. Morisot, J. Alder, C. G. Liu, S. Heimfeld, G. A. Calin, C. M. Croce, and C. I. Civin. 2007. CD34+ hematopoietic stemprogenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. USA 104: 2750-2755.
29. Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269.
30. Koralov, S. B., S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty, C. Kanellopoulou, K. Jensen, B. S. Cobb, M. Merkenschlager, N. Rajewsky, and K. Rajewsky. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874.
31. Zhou, B., S. Wang, C. Mayr, D. P. Bartel, and H. F. Lodish. 2007. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 104: 7080-7085.
32. Fukao, T., Y. Fukuda, K. Kiga, J. Sharif, K. Hino, Y. Enomoto, A. Kawamura, K. Nakamura, T. Takeuchi, and M. Tanabe. 2007. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129: 617-631.
33. Fazi, F., A. Rosa, A. Fatica, V. Gelmetti, M. L. De Marchis, C. Nervi, and I. Bozzoni. 2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: 819-831.
34. Garzon, R., F. Pichiorri, T. Palumbo, R. Iuliano, A. Cimmino, R. Aqeilan, S. Volinia, D. Bhatt, H. Alder, G. Marcucci, et al. 2006. MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. USA 103: 5078-5083.
35. Lu, J., S. Guo, B. L. Ebert, H. Zhang, X. Peng, J. Bosco, J. Pretz, R. Schlanger, J. Y. Wang, R. H. Mak, et al. 2008. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev. Cell 14: 843-853.
36. Navarro, F., D. Gutman, E. Meire, M. Cáceres, I. Rigoutsos, Z. Bentwich, and J. Lieberman. 2009. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 114: 2181-2192.
37. Felli, N., L. Fontana, E. Pelosi, R. Botta, D. Bonci, F. Facchiano, F. Liuzzi, V. Lulli, O. Morsilli, S. Santoro, et al. 2005. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. USA 102: 18081-18086.
38. Dore, L. C., J. D. Amigo, C. O. Dos Santos, Z. Zhang, X. Gai, J. W. Tobias, D. Yu, A. M. Klein, C. Dorman, W. Wu, et al. 2008. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. Natl. Acad. Sci. USA 105: 3333-3338.
39. Calin, G. A., C. Sevignani, C. D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini, and C. M. Croce. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101: 2999-3004.
40. Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
41. Calin, G. A., C. D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, et al. 2002. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99: 15524-15529.
42. Cimmino, A., G. A. Calin, M. Fabbri, M. V. Iorio, M. Ferracin, M. Shimizu, S. E. Wojcik, R. I. Aqeilan, S. Zupo, M. Dono, et al. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 102: 13944-13949.
43. Calin, G. A., A. Cimmino, M. Fabbri, M. Ferracin, S. E. Wojcik, M. Shimizu, C. Taccioli, N. Zanesi, R. Garzon, R. I. Aqeilan, et al. 2008. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. USA 105: 5166-5171.
44. Calin, G. A., M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S. E. Wojcik, M. V. Iorio, R. Visone, N. I. Sever, M. Fabbri, et al. 2005. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353: 1793-1801.
45. Fulci, V., S. Chiaretti, M. Goldoni, G. Azzalin, N. Carucci, S. Tavolaro, L. Castellano, A. Magrelli, F. Citarella, M. Messina, et al. 2007. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
46. Marton, S., M. R. Garcia, C. Robello, H. Persson, F. Trajtenberg, O. Pritsch, C. Rovira, H. Naya, G. Dighiero, and A. Cayota. 2008. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22: 330-338.
47. Wang, M., L. P. Tan, M. K. Dijkstra, K. van Lom, J. L. Robertus, G. Harms, T. Blokzijl, K. Kooistra, M. B. van T'veer, S. Rosati, et all. 2008. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J. Pathol. 215: 13-20.
48. Venturini, L., K. Battmer, M. Castoldi, B. Schultheis, A. Hochhaus, M. U. Muckenthaler, A. Ganser, M. Eder, and M. Scherr. 2007. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109: 4399-4405.
49. Bueno, M. J., I. Pérez de Castro, M. Gómez de Cedrón, J. Santos, G. A. Calin, J. C. Cigudosa, C. M. Croce, J. Fernández-Piqueras, and M. Malumbres. 2008. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506.
50. Mi, S., J. Lu, M. Sun, Z. Li, H. Zhang, M. B. Neilly, Y. Wang, Z. Qian, J. Jin, Y. Zhang, et al. 2007. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 104: 19971-19976.
51. Fulci, V., T. Colombo, S. Chiaretti, M. Messina, F. Citarella, S. Tavolaro, A. Guarini, R. Foà, and G. Macino. 2009. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer 48: 1069-1082.
52. Sonoki, T., E. Iwanaga, H. Mitsuya, and N. Asou. 2005. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 19: 2009-2010.
53. Mrózek, K., M. D. Radmacher, C. D. Bloomfield, and G. Marcucci. 2009. Molecular signatures in acute myeloid leukemia. Curr. Opin. Hematol. 16: 64-69.
54. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, M. P. Boldin, K. D. Taganov, J. Nicoll, R. L. Paquette, and D. Baltimore. 2008. Sustained expression of microRNA- 155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205: 585-594.
55. Bousquet, M., C. Quelen, R. Rosati, V. Mansat-De Mas, R. La Starza, C. Bastard, E. Lippert, P. Talmant, M. Lafage-Pochitaloff, D. Leroux, et al. 2008. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J. Exp. Med. 205: 2499-2506.
56. Garzon, R., C. E. Heaphy, V. Havelange, M. Fabbri, S. Volinia, T. Tsao, N. Zanesi, S. M. Kornblau, G. Marcucci, G. A. Calin, et al. 2009. MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341.
57. Lawrie, C. H. 2007. MicroRNA expression in lymphoma. Expert Opin. Biol. Ther. 7: 1363-1374.
58. Costinean, S., S. K. Sandhu, I. M. Pedersen, E. Tili, R. Trotta, D. Perrotti, D. Ciarlariello, P. Neviani, J. Harb, L. R. Kauffman, et al. 2009. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 114: 1374-1382.
59. Chang, T. C., D. Yu, Y. S. Lee, E. A. Wentzel, D. E. Arking, K. M. West, C. V. Dang, A. Thomas-Tikhonenko, and J. T. Mendell. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40: 43-50.
60. Sander, S., L. Bullinger, K. Klapproth, K. Fiedler, H. A. Kestler, T. F. Barth, P. Möller, S. Stilgenbauer, J. R. Pollack, and T. Wirth. 2008. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 112: 4202-4212.
61. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
62. Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F. N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28: 621-629.
63. Chong, M. M., J. P. Rasmussen, A. Y. Rudensky, A. Y. Rundensky, and D. R. Littman. 2008. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205: 2005-2017.
64. Liston, A., L. F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205: 1993-2004.
65. Zhou, X., L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205: 1983-1991.
66. Lu, L. F., T. H. Thai, D. P. Calado, A. Chaudhry, M. Kubo, K. Tanaka, G. B. Loeb, H. Lee, A. Yoshimura, K. Rajewsky, and A. Y. Rudensky. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91.
67. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
68. O'Connell, R. M., K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104: 1604-1609.
69. Ceppi, M., P. M. Pereira, I. Dunand-Sauthier, E. Barras, W. Reith, M. A. Santos, and P. Pierre. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 106: 2735-2740.
70. Lawrie, C. H., S. Gal, H. M. Dunlop, B. Pushkaran, A. P. Liggins, K. Pulford, A. H. Banham, F. Pezzella, J. Boultwood, J. S. Wainscoat, et al. 2008. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141: 672-675.
71. Petrocca, F., and J. Lieberman. 2009. Micromanipulating cancer: microRNA-based therapeutics? RNA Biol. 6: 335-340.
72. Lanford, R. E., E. S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. E. Munk, S. Kauppinen, and H. Ørum. 2010. Therapeutic silencing of micro RNA in primates with chronic hepatitis C virus infection. Science 327: 198-201.
73. de Fougerolles, A., H. P. Vornlocher, J. Maraganore, and J. Lieberman. 2007. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 6: 443-453.
74. Kumar, P., H. S. Ban, S. S. Kim, H. Wu, T. Pearson, D. L. Greiner, A. Laouar, J. Yao, V. Haridas, K. Habiro, et al. 2008. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134: 577-586.
75. McNamara, J. O., II, E. R. Andrechek, Y. Wang, K. D. Viles, R. E. Rempel, E. Gilboa, B. A. Sullenger, and P. H. Giangrande. 2006. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24: 1005-1015.
76. Peer, D., E. J. Park, Y. Morishita, C. V. Carman, and M. Shimaoka. 2008. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 319: 627-630.
77. Peer, D., P. Zhu, C. V. Carman, J. Lieberman, and M. Shimaoka. 2007. Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc. Natl. Acad. Sci. USA 104: 4095-4100.
78. Song, E., P. Zhu, S. K. Lee, D. Chowdhury, S. Kussman, D. M. Dykxhoorn, Y. Feng, D. Palliser, D. B. Weiner, P. Shankar, et al. 2005. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23: 709-717.